Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Aug 2013 11:00 AM
RNS
Result of General Meeting
05 Aug 2013 07:00 AM
RNS
Appointment of a Non-Executive Director
25 Jul 2013 07:00 AM
RNS
Expansion of Collaboration with ForteBio
18 Jul 2013 07:00 AM
RNS
Conditional Placing to Raise ?4.7 Million
23 May 2013 08:40 AM
RNS
Holding(s) in Company
30 Apr 2013 07:00 AM
RNS
Interim Results
23 Apr 2013 07:01 AM
RNS
Notice of Interim Results
23 Apr 2013 07:00 AM
RNS
Appointment of Nominated Advisor and Broker
27 Feb 2013 07:00 AM
RNS
Interest in Affimer Technology
27 Feb 2013 07:00 AM
RNS
Business Update
18 Feb 2013 05:08 PM
RNS
Additional Listing
25 Jan 2013 02:34 PM
RNS
Result of AGM
21 Jan 2013 01:20 PM
RNS
Holding(s) in Company
07 Jan 2013 03:47 PM
RNS
Holding(s) in Company
23 Oct 2012 07:00 AM
RNS
Preliminary Results
24 Sep 2012 07:00 AM
RNS
Avacta and Pall extend Optim distribution to India
13 Sep 2012 10:24 AM
RNS
Notice of Preliminary Results
24 Aug 2012 07:00 AM
RNS
Pre-close trading update
19 Jun 2012 05:05 PM
RNS
Holding(s) in Company
25 Apr 2012 07:00 AM
RNS
Interim Results
02 Apr 2012 07:00 AM
RNS
Avacta Signs Exclusive Supply Deal with IDEXX
15 Mar 2012 07:00 AM
RNS
Notice of Interim Results
24 Jan 2012 10:39 AM
RNS
Result of AGM
19 Jan 2012 06:23 PM
RNS
Holding(s) in Company
12 Jan 2012 11:12 AM
RNS
Holding(s) in Company
10 Jan 2012 09:26 AM
RNS
Completes ?5.13m placing and Aptuscan acquisition
09 Jan 2012 04:10 PM
RNS
Results of General Meeting
22 Dec 2011 07:00 AM
RNS
Conditional Placing and Proposed Acquisition
08 Dec 2011 02:20 PM
RNS
Notice of AGM and Report and Accounts
25 Nov 2011 07:00 AM
RNS
Additional Listing & Total Voting Rights
25 Oct 2011 07:00 AM
RNS
Preliminary Results
21 Oct 2011 07:00 AM
RNS
Appointment of Nomad and Broker
05 Oct 2011 07:00 AM
RNS
South East Asian Alliance agreed with Pall
19 Sep 2011 07:00 AM
RNS
Notice of Preliminary Results
09 Aug 2011 07:00 AM
RNS
Pre-close Trading Update
06 Jul 2011 07:00 AM
RNS
Change of Registered Office
13 Jun 2011 07:00 AM
RNS
Avacta & Pall Corp form new collaborative venture
10 Jun 2011 12:50 PM
RNS
Director/PDMR Shareholding
31 May 2011 07:00 AM
RNS
Avacta secures second Optim sale in US
18 Apr 2011 07:00 AM
RNS
Interim Results
12 Apr 2011 12:42 PM
RNS
Issue of Equity
29 Mar 2011 07:00 AM
RNS
Exclusive distribution agreement with DKSH Japan
28 Mar 2011 08:00 AM
RNS
Additional Listing
28 Mar 2011 07:00 AM
RNS
Additional Listing
22 Mar 2011 10:11 AM
RNS
Additional Listing
17 Mar 2011 07:00 AM
RNS
Directorate Change
04 Mar 2011 07:00 AM
RNS
Trading Statement
23 Feb 2011 07:00 AM
RNS
Re Agreement
03 Feb 2011 07:00 AM
RNS
Re Agreement
03 Feb 2011 07:00 AM
RNS
Issue of Equity

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.

It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Avacta Group share price launched at 5,448p in 2003. 

UK 100